Correction: Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study
This 2024 correction addresses the original 2017 randomized, double-blinded, placebo-controlled trial that evaluated the efficacy of intra-articular ozone injections in patients with knee osteoarthritis (KOA). The study involved 98 participants who received either ozone (20 μg/mL) or placebo injections over 8 weeks. Outcomes measured included pain (VAS), function (WOMAC, Lequesne